|
|
Received: 01 January 2023
|
|
|
|
|
[1] |
王奕琪,吕志军,张玲菊,等. 吉兰-巴雷综合征谱系病合并自主神经损伤的临床特点分析[J]. 现代实用医学,2019,31(4):440-441.
|
[2] |
赵 娟,李 然,颜 榕,等. 吉兰-巴雷综合征合并视神经炎四例临床特点[J]. 中华医学杂志,2019(47):3744-3745.
|
[3] |
Yazdanpanah N, Rezaei N. Autoimmune complications of COVID-19[J]. J Med Virol,2022,94(1):54-62.
|
[4] |
Sriwastava S, Kataria S, Tandon M, et al. Guillain barre syndrome and its variants as a manifestation of COVID-19: A systematic review of case reports and case series[J]. J Neurol Sci,2021,420:117263.
|
[5] |
中华医学会神经病学分会,中华医学会神经病学分会周围神经病协作组,中华医学会神经病学分会肌电图与临床神经电生理学组,等. 中国吉兰-巴雷综合征诊治指南2019[J]. 中华神经科杂志,2019(11):877-878.
|
[6] |
Wakerley B R, Uncini A, Yuki N. Guillain-Barré and Miller Fisher syndromes—new diagnostic classification[J]. Nat Rev Neurol,2014,10(9):537-544.
|
[7] |
李 华,郭志娟. 以共济失调为首发症状的遗传性转甲状腺素蛋白淀粉样变1例[J]. 武警医学,2023,34(1):49-52.
|
[8] |
Yuki N, Uncini A. Acute and chronic ataxic neuropathies with disialosyl antibodies: a continuous clinical spectrum and a common pathophysiological mechanism[J]. Muscle Nerve,2014,49(5):629-635.
|
[9] |
Zhang Y, Zhao Y, Wang Y. Prognostic factors of Guillain-Barre syndrome: a 111-case retrospective review[J]. Chin Neurosurg J,2018,4:14.
|
[10] |
Doets A Y, Verboon C, van den Berg B, et al. Regional variation of Guillain-Barré syndrome[J]. Brain,2018,141(10):2866-2877.
|
[11] |
Leonhard S E, Mandarakas M R, Gondim F, et al. Diagnosis and management of Guillain-Barre syndrome in ten steps[J]. Nat Rev Neurol,2019,15(11):671-683.
|
[12] |
Lleixà C, Martín-Aguilar L, Pascual-Goñi E, et al. Autoantibody screening in Guillain–Barré syndrome[J]. J Neuroinflamm,2021,18(1).
|
[13] |
Yoshikawa K, Kuwahara M, Morikawa M, et al. Varied antibody reactivities and clinical relevance in anti-GQ1b antibody-related diseases[J]. Neurology-Neuroimmunology Neuroinflammation,2018,5(6):e501.
|
[14] |
Liu J X, Willison H J, Pedrosa-Domellof F. Immunolocalization of GQ1b and related gangliosides in human extraocular neuromuscular junctions and muscle spindles[J]. Invest Ophthalmol Vis Sci,2009,50(7):3226-3232.
|
[15] |
Kaida K, Kamakura K, Ogawa G, et al. GD1b-specific antibody induces ataxia in Guillain-Barre syndrome[J]. Neurology,2008,71(3):196-201.
|
[1] |
. [J]. Med. J. Chin. Peop. Armed Poli. Forc., 2018, 29(5): 521-522. |
|
|
|